Biobot Surgical Pte Ltd

About Biobot Surgical Pte Ltd

Founded in 2007, Biobot Surgical is a Singapore-based medical technology company developing digital robotic solutions for precision prostate cancer care. Its flagship Mona Lisa platform combines MRI-ultrasound fusion and robotic transperineal guidance to support accurate prostate biopsy and focal therapy. Biobot is expanding the platform into an integrated digital ecosystem that connects robotics, medical imaging, AI and clinical data to enable more precise, reproducible and personalized diagnosis and treatment, with regulatory approvals in major global markets including the US, Europe, and Asia-Pacific.